Hemofília: vizsgálatok itt: Törökország
13 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in TörökországSafety of Intraosseous Anaesthesia in Children With Haemophilia
- Where
- Ankara
- Életkor
- 4 év to 12 év
- People
- 20
- Run by
- Ankara Yildirim Beyazıt University
See details and how to joinNCT07916467 - 3. fázisTaking peopleA Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
- Where
- Ankara, Istanbul, Izmir
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07830732 · EU 2026-525529-19-00 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
- Where
- Istanbul, Izmir
- Életkor
- 1 év to 11 év
- People
- 85 worldwide
- Run by
- Sanofi
See details and how to joinNCT07285460 · EU 2025-521858-42-00 - 3. fázisTaking peopleOpen-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Where
- Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Samsun
- Életkor
- 1 év to 74 év
- People
- 245 worldwide
- Run by
- Pfizer
See details and how to joinNCT05145127 · EU 2022-500470-33-00 - 1. fázisTaking peopleA Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
- Where
- Bornova, Fatih
- Életkor
- 12 év to 74 év
- People
- 15 worldwide
- Run by
- Pfizer
See details and how to joinNCT06703606 - 3. fázisTaking peopleA Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
- Where
- Adana, Ankara, Istanbul, Izmir, Kayseri, Melikgazi, Samsun
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05611801 · EU 2022-500495-65-00 - 3. fázisTaking peopleSafety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Where
- Adana, Gaziantep, Istanbul, Izmir
- Életkor
- 18 év and over
- People
- 173 worldwide
- Run by
- Pfizer
See details and how to joinNCT05568719 - No phaseTaking peopleValidity and Reliability of the Figure-of-Eight Walking and Weight-Bearing Lunge Tests in Hemophilia
- Where
- Van
- Életkor
- 18 év to 65 év
- People
- 36
- Run by
- Yuzuncu Yil University
See details and how to joinNCT07851922 - 3. fázisTaking peopleEfficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
- Where
- Bornova, Gaziantep, Seyhan
- Életkor
- 18 év and over
- People
- 35 worldwide
- Run by
- CSL Behring
See details and how to joinNCT06003387 · EU 2023-509590-23-00 - No phaseTaking peopleEfficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
- Where
- Fatih
- People
- 200 worldwide
- Run by
- Octapharma
See details and how to joinNCT03695978 - No phaseTaking peopleJoint Health, Balance and Quality of Life in Adults With Hemophilia A
- Where
- Van
- Életkor
- 18 év to 65 év
- People
- 36
- Run by
- Yuzuncu Yil University
See details and how to joinNCT07523399 - No phaseNot yet taking people in TörökországEffects of Emicizumab Treatment in Patients With Hemophilia A
- Where
- Gaziantep
- Életkor
- 1 év to 18 év
- People
- 20
- Run by
- Hasan Kalyoncu University
See details and how to joinNCT07190118 - No phaseCsak meghívásosComparison of Upper Extremity Functional Performance in Hemophilic and Healthy Children
- Where
- Ankara
- Életkor
- 7 év to 17 év
- People
- 30
- Run by
- Hacettepe University
See details and how to joinNCT06826209